PRMT5 inhibition as a therapeutic strategy for KRAS mutant CRC: downstream mediators of the PRMT5-KRAS crosstalk

被引：1
|
作者：
Shifteh, David
Sapir, Tzuriel
Pahmer, Moshe
Goel, Sanjay
Maitra, Radhashree
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
534
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Molecular dynamic simulation of intermediates connecting KRAS and PRMT5 insight for targeting KRAS
    Silverman, Isaac V.
    Stein, Yitzchak F.
    Gerber, Michael Shawn
    Maitra, Radhashree
    Goel, Sanjay
    CANCER RESEARCH, 2023, 83 (07)
  • [2] FGFR3 and eIF4E are overexpressed and interact with PRMT5 and KRAS in CRC.
    Shifteh, David
    Sapir, Tzuriel
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    CANCER RESEARCH, 2021, 81 (13)
  • [3] PRMT1 loss sensitizes cells to PRMT5 inhibition
    Gao, Guozhen
    Zhang, Liang
    Villarreal, Oscar D.
    He, Wei
    Su, Dan
    Bedford, Ella
    Moh, Phoebe
    Shen, Jianjun
    Shi, Xiaobing
    Bedford, Mark T.
    Xu, Han
    NUCLEIC ACIDS RESEARCH, 2019, 47 (10) : 5038 - 5048
  • [4] Protein arginine methyltransferase 5 (PRMT5) inhibition as a therapeutic strategy in B-cell lymphoma
    Barbash, Olena
    Gerhart, Sarah
    Soong, David
    Thompson, Christine
    de Oca, Rocio Montes
    Zhang, Ping
    McHugh, Charles
    Kuplast, Kristy
    Majer, Christina
    Chesworth, Richard
    Smith, Jesse
    Copeland, Robert
    Penebre, Elayne
    Duncan, Kenneth
    Johnson, Neil
    Carpenter, Chris
    Kruger, Ryan
    CANCER RESEARCH, 2015, 75
  • [5] Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria U.
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Arnes-Benito, Robert
    Adan-Villaescusa, Elena
    Martinez-Perez, Luz A.
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Gardini, Andrea Casadei
    Marin, Jose J. G.
    Amat, Irene
    Urman, Jesus M.
    Arechederra, Maria
    Luz Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Javier Cubero, Francisco
    Berasain, Carmen
    Fernandez-Barrena, Maite G.
    Avila, Matias A.
    GUT, 2025, 74 (01) : 116 - 127
  • [6] IDENTIFICATION OF PRMT5 AS A THERAPEUTIC TARGET IN CHOLANGIOCARCINOMA
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria Ujue
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Benito, Robert Arnes
    Adan-Villaescusa, Elena
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Casadei-Gardini, Andrea
    Marin, Jose
    Amat, Irene
    Urman, Jesus
    Arechederra, Maria
    Martinez-Chantar, Maria
    Trautwein, Christian
    Huch, Meritxell
    Cubero, Francisco Javier
    Berasain, Carmen
    Fernandez-Barrena, Maite
    Avila, Matias
    HEPATOLOGY, 2024, 80
  • [7] PRMT5 is a therapeutic target in choroidal neovascularization
    Muniyandi, Anbukkarasi
    Martin, Matthew
    Sishtla, Kamakshi
    Motolani, Aishat
    Sun, Mengyao
    Jensen, Nathan R.
    Qi, Xiaoping
    Boulton, Michael E.
    Prabhu, Lakshmi
    Lu, Tao
    Corson, Timothy W.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
    Elurbide, Jasmin
    Colyn, Leticia
    Latasa, Maria U.
    Uriarte, Iker
    Mariani, Stefano
    Lopez-Pascual, Amaya
    Valbuena, Emiliana
    Castello-Uribe, Borja
    Arnes-Benito, Robert
    Adan-Villaescusa, Elena
    Martinez-Perez, Luz A.
    Azkargorta, Mikel
    Elortza, Felix
    Wu, Hanghang
    Krawczyk, Marcin
    Schneider, Kai Markus
    Sangro, Bruno
    Aldrighetti, Luca
    Ratti, Francesca
    Casadei Gardini, Andrea
    Marin, Jose J. G.
    Amat, Irene
    Urman, Jesus M.
    Arechederra, Maria
    Martinez-Chantar, Maria Luz
    Trautwein, Christian
    Huch, Meritxell
    Cubero, Francisco Javier
    Berasain, Carmen
    Fernandez-Barrena, Maite
    Avila, Matias A.
    GUT, 2024, 74 (01)
  • [9] Antitumor Effects of PRMT5 Inhibition in Sarcomas
    Verbeke, Stephanie
    Bourdon, Aurelien
    Guegan, Jean-Philippe
    Leroy, Laura
    Chaire, Vanessa
    Richard, Elodie
    Bessede, Alban
    Italiano, Antoine
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (11): : 2211 - 2220
  • [10] PRMT5 is a therapeutic target in choroidal neovascularization
    Anbukkarasi Muniyandi
    Matthew Martin
    Kamakshi Sishtla
    Aishat Motolani
    Mengyao Sun
    Nathan R. Jensen
    Xiaoping Qi
    Michael E. Boulton
    Lakshmi Prabhu
    Tao Lu
    Timothy W. Corson
    Scientific Reports, 13
12345